Market Research Logo

US Product Portfolio for Vascular Access Devices and Accessories 2016 - MedFolio

The U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound machines, tip guidance devices, catheter securement devices, syringes and needles.


EXECUTIVE SUMMARY
1.1 U.S. VASCULAR ACCESS DEVICES AND ACCESSORIES MARKET OVERVIEW
1.2 COMPETITIVE LANDSCAPE
1.3 MARKET TRENDS
1.4 KEY MARKET DEVELOPMENTS
1.5 MARKETS INCLUDED
1.6 PROCEDURES INCLUDED
1.7 PROCEDURE CODES INVESTIGATED
1.8 KEY REPORT UPDATES
1.9 VERSION HISTORY
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
3.1 PRODUCT PORTFOLIOS
3.1.1 Implantable Port Devices
3.1.1.1 Introduction
3.1.1.1.1 Implantable Port Patients
3.1.1.1.2 Port Implantation Procedures
3.1.1.1.3 Port Infusion
3.1.1.1.4 Port Maintenance
3.1.1.2 AngioDynamics
3.1.1.2.1 BioFlo®
3.1.1.2.2 LifePort®
3.1.1.2.3 Smart Port® CT
3.1.1.2.4 TitanPort®
3.1.1.2.5 Triumph-1®
3.1.1.2.6 Vortex®
3.1.1.2.7 Xcela™ Plus
3.1.1.3 B. Braun
3.1.1.3.1 Celsite®
3.1.1.4 Cook Medical
3.1.1.4.1 Vital-Port®
3.1.1.5 C.R. Bard
3.1.1.5.1 PowerPort®
3.1.1.5.2 SlimPort®
3.1.1.5.3 X-Port™
3.1.1.5.4 Other Port Offerings
3.1.1.6 Medcomp
3.1.1.6.1 Dignity®
3.1.1.6.2 Pro-Fuse® CT
3.1.1.7 PFM Medical
3.1.1.7.1 T-Port™
3.1.1.7.2 TitaJet™
3.1.1.7.3 Jet Port®
3.1.1.7.4 DualPort
3.1.1.8.1 P.A.S. PORT®
3.1.1.8.2 PORT-A-CATH®
3.1.1.9 Teleflex Medical
3.1.1.9.1 Polysite®
3.1.2 Port Needles
3.1.2.1 Introduction
3.1.2.2 AngioDynamics
3.1.2.2.1 LifeGuard®
3.1.2.2.2 LifePort®
3.1.2.3 B. Braun
3.1.2.3.1 WHIN®
3.1.2.4 Cook Medical
3.1.2.4.1 Vital-Ject™
3.1.2.5 C. R. Bard
3.1.2.5.1 PowerLoc®
3.1.2.5.2 Other Port Needle Offerings
3.1.2.6 Kawasumi
3.1.2.6.1 K-Shield®
3.1.2.6.2 Other Port Needle Offerings
3.1.2.7 MPS Medical, Inc.
3.1.2.7.1 SmartSafety®
3.1.2.8 Nipro Medical
3.1.2.8.1 SafeTouch™
3.1.2.9 Smiths Medical
3.1.2.9.1 GRIPPER®
3.1.2.9.2 GRIPPER PLUS®
3.1.2.9.3 Other Port Needle Offerings
3.1.2.10 Vygon (Churchill Medical Systems)
3.1.2.10.1 LifeGuard™
3.1.2.10.2 Wing Safe™
3.1.3 Central Venous Catheters
3.1.3.1 Introduction
3.1.3.1.2 CVC Kits
3.1.3.1.3 CVC Market Segments
3.1.3.2 AngioDynamics
3.1.3.2.1 NeoStar™
3.1.3.3 Centurion Medical Products
3.1.3.3.1 Vantex™
3.1.3.3.2 Multi-Med™
3.1.3.3.3 AVA™
3.1.3.4 Cook Medical
3.1.3.4.1 Spectrum®
3.1.3.5 C.R. Bard
3.1.3.5.1 PowerHohn®
3.1.3.5.2 Hohn®
3.1.3.5.3 Other CVC Offerings
3.1.3.6 Medcomp Inc.
3.1.3.6.1 Pro-Line®
3.1.3.6.2 Vascu-Line®
3.1.3.6.3 Other CVC Offerings
3.1.3.7 Teleflex Medical
3.1.3.7.1 Standard
3.1.3.7.2 ARROWg+ard Blue®
3.1.3.7.3 ARROWg+ard Blue Plus®
3.1.3.7.4 Chlorag+ard®
3.1.4 Peripherally Inserted Central Catheters
3.1.4.1 Introduction
3.1.4.1.1 PICC Placement
3.1.4.2 AngioDynamics
3.1.4.2.1 BioFlo®
3.1.4.3 Argon Medical
3.1.4.3.1 First PICC™
3.1.4.3.2 L-Cath™
3.1.4.4 B. Braun
3.1.4.4.2 Other PICC Offerings
3.1.4.5 Cook Medical
3.1.4.5.1 Spectrum®
3.1.4.5.2 Other PICC Offerings
3.1.4.6 C.R. Bard
3.1.4.6.1 PowerPICC®
3.1.4.6.2 Groshong®
3.1.4.6.3 Per-Q-Cath®
3.1.4.6.4 Other PICC Offerings
3.1.4.7 GaltNeedleTech
3.1.4.7.1 SYNERGY™
3.1.4.8 Medcomp
3.1.4.8.1 Pro-PICC™
3.1.4.8.2 Vascu-PICC™
3.1.4.9 Neo Medical
3.1.4.9.1 Neo-Magic™
3.1.4.9.2 V-Cath™
3.1.4.10 PFM Medical
3.1.4.10.1 pfm CT PICC II
3.1.4.11 Teleflex Medical
3.1.4.11.1 ARROW®
3.1.4.12 Trinity Sterile
3.1.4.12.1 Trinity™ PICC II
3.1.4.13 Vygon
3.1.4.13.1 Premicath™
3.1.4.13.2 Epicutaneo-Cava™
3.1.4.13.3 Nutriline™
3.1.4.13.4 Lifecath™
3.1.5 Peripheral Intravenous Catheters
3.1.5.1 Introduction
3.1.5.2 Access Scientific
3.1.5.2.1 POWERWAND®
3.1.5.3.1 BioFlo®
3.1.5.4 Argon Medical
3.1.5.4.1 First Midcath™
3.1.5.4.2 L-Cath™
3.1.5.5 B. Braun
3.1.5.5.1 Introcan Safety®
3.1.5.6 Becton Dickinson
3.1.5.6.1 Nexiva™
3.1.5.6.2 Saf-T-Intima™
3.1.5.6.3 Autoguard™
3.1.5.7 C.R. Bard
3.1.5.7.1 AccuCath®
3.1.5.7.2 PowerGlide®
3.1.5.7.3 Bard® Poly
3.1.5.7.4 Other Midline Offerings
3.1.5.8 GaltNeedleTech
3.1.5.8.1 Nexus™
3.1.5.9 Medcomp
3.1.5.9.1 Medcomp® Midline
3.1.5.10 MediKit
3.1.5.10.1 Supercath™
3.1.5.11 Neo Medical
3.1.5.11.1 PowerStick™
3.1.5.11.2 Neo-Magic®
3.1.5.12 Nipro Medical
3.1.5.12.1 Nipro™ IV Catheter
3.1.5.13 Retractable Technologies, Inc.
3.1.5.13.1 VanishPoint®
3.1.5.14 Smiths Medical
3.1.5.14.1 ViaValve™
3.1.5.14.2 PROTECTIV®
3.1.5.14.3 ACUVANCE®
3.1.5.14.4 Other PIVC offerings
List of Chart
Chart 0-1: Vascular Access Device Market by Segment, U.S., 2012 – 2022
Chart 0-2: Vascular Access Device Market Overview, U.S., 2015 and 2022
Chart 3-1: Central Venous Catheter Market Segments, U.S., 2015
List of Figures
Figure 0-1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, U.S., 2015 (1 of 2)
Figure 0-2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, U.S., 2015 (2 of 2)
Figure 0-3: Companies Researched in Report, U.S., 2015
Figure 0-4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, U.S.
Figure 0-5: Recent Events in the Vascular Access Device and Accessories Market, U.S., 2012 – 2015
Figure 0-6: Vascular Access Devices & Accessories Markets Covered, U.S., 2015 (1 of 3)
Figure 0-7: Vascular Access Devices & Accessories Markets Covered, U.S., 2015 (2 of 3)
Figure 0-8: Vascular Access Devices & Accessories Markets Covered, U.S., 2015 (3 of 3)
Figure 0-9: Vascular Access Devices & Accessories Procedures Covered, U.S., 2015
Figure 0-10: Procedural Codes, U.S., 2015
Figure 0-11: Key Report Updates, U.S., 2014 and 2016 (1 of 2)
Figure 0-12: Key Report Updates, U.S., 2014 and 2016 (2 of 2)
Figure 0-13: Version History
Figure 3-1: Class 2 Device Recall Medtronic
Figure 3-2: Class 2 Device Recall Smiths Medical
Figure 3-3: Class 2 Device Recall Arrow
Figure 3-4: Class 2 Device Recall Arrow
Figure 3-5: Class 2 Device Recall Covidien
Figure 3-6: Class 2 Device Recall Arrow
Figure 3-7: Class 2 Device Recall Medline
Figure 3-8: Class 2 Device Recall Arrow
Figure 3-9: Class 2 Device Recall B. Braun
Figure 3-10: Class 3 Device Recall Bard Access
Figure 3-11: Class 2 Device Recall Covidien
Figure 3-12: Class 2 Device Recall Bard Access
Figure 3-13: Class 2 Device Recall Bard Access
Figure 3-14: Class 2 Device Recall Medcomp & AngioDynamics
Figure 3-15: Class 2 Device Recall Bard Access
Figure 3-16: Class 2 Device Recall Arrow
Figure 3-17: Class 2 Device Recall Medcomp
Figure 3-18: Class 2 Device Recall Arrow
Figure 3-19: Class 2 Device Recall Arrow
Figure 3-20: Class 2 Device Recall Smiths Medical
Figure 3-21: Class 2 Device Recall PFM Medical
Figure 3-22: Class 2 Device Recall PFM Medical
Figure 3-23: Class 2 Device Recall Becton Dickinson
Figure 3-24: Class 2 Device Recall Arrow
Figure 3-25: Class 2 Device Recall Arrow
Figure 3-26: Class 2 Device Recall Navilyst Medical
Figure 3-27: Class 2 Device Recall Argon Medical
Figure 3-28: Class 2 Device Recall Arrow
Figure 3-29: Class 2 Device Recall Arrow
Figure 3-30: Class 2 Device Recall Arrow
Figure 3-31: Class 2 Device Recall Bard Access
Figure 3-32: Class 2 Device Recall Navilyst Medical
Figure 3-33: Class 2 Device Recall Bard Access
Figure 3-34: Class 2 Device Recall Smiths Medical
Figure 3-35: Class 2 Device Recall B. Braun
Figure 3-36: Class 2 Device Recall Smiths Medical
Figure 3-37: Class 2 Device Recall Access Scientific
Figure 3-38: Class 2 Device Recall Covidien
Figure 3-39: Class 2 Device Recall Arrow
Figure 3-40: Class 2 Device Recall Bard Access
Figure 3-41: Class 2 Device Recall Becton Dickinson
Figure 3-42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3-43: Class 2 Device Recall Bard Access
Figure 3-44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3-45: Class 2 Device Recall Medcomp
Figure 3-46: Class 2 Device Recall Becton Dickinson
Figure 3-47: Class 3 Device Recall Bard Access
Figure 3-48: Class 2 Device Recall Medcomp
Figure 3-49: Class 1 Device Recall Arrow
Figure 3-50: Class 2 Device Recall Arrow
Figure 3-51: Class 2 Device Recall Vygon
Figure 3-52: Class 2 Device Recall Covidien
Figure 3-53: Class 2 Device Recall Medcomp
Figure 3-54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3-55: Class 2 Device Recall Christie Medical Holdings
Figure 3-56: Class 3 Recall Bard Access
Figure 3-57: Class 2 Device Recall AngioDynamics
Figure 3-58: Class 2 Device Recall Becton Dickinson
Figure 3-59: Class 2 Device Recall AngioDynamics
Figure 3-60: Class 2 Device Recall AngioDynamics
Figure 3-61: Class 3 Device Recall AngioDynamics
Figure 3-62: Class 2 Device Recall AngioDynamics
Figure 3-63: Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment
Figure 3-64: A Pragmatic Randomized Trial
Figure 3-65: Assessment of a Power Injectable vs. a Non-Power Injectable
Figure 3-66: Vascular Access in Cancer Patients
Figure 3-67: Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection
Figure 3-68: Central Line Placement Study
Figure 3-69: The Effects of Anti-infective Central Venous Catheter (CVC)
Figure 3-70: The Use of Point of Care Ultra Sound
Figure 3-71: Complications Associated With Central Venous Access
Figure 3-72: Impact of Ultrasound Guided Central Venous Catheterization
Figure 3-73: Randomized, Prospective, Single-center Study
Figure 3-74: Remifentanil and Local Anesthesia
Figure 3-75: Dissemination of a Simulation-based Mastery Learning Curriculum
Figure 3-76: Incidence of Complication
Figure 3-77: Comparison of Two Needle Insertion Techniques
Figure 3-78: A Monocenter Prospective Study
Figure 3-79: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography
Figure 3-80: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation
Figure 3-81: Use of Chlorhexidine-gel-Impregnated Dressing Compared to Transparent Polyurethane Film Dressing
Figure 3-82: Vascular Access in Hematological Patients
Figure 3-83: Developing and Maintaining a Central Venous Catheter Registry
Figure 3-84: Reliability of Central Venous Pressure Measurements
Figure 3-85: SUBclavian Central Venous Catheters Guidance and Examination by UltraSound
Figure 3-86: Chlorhexidine Containing IV-securement Dressings
Figure 3-87: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters
Figure 3-88: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters
Figure 3-89: Ultrasound Guided Diagnosis of Central Venous Catheters in Children
Figure 3-90: Real-time Ultrasound-guided Catheterization of the Axillary Vein in the Intensive Care Unit
Figure 3-91: Determination of Anatomic Variations of the Internal Jugular and Femoral Veins
Figure 3-92: Comparison of Subclavian, Femoral and Internal Jugular Venous Catheterization
Figure 3-93: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement
Figure 3-94: Interest of Ultrasound Coupled to a Guidance System (GPS)
Figure 3-95: Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement
Figure 3-96: Comparison of the Central Venous Catheter Insertion Techniques
Figure 3-97: A Multicenter, Open-label, Randomised, Clinical Trial
Figure 3-98: A Pragmatic Randomized Trial Standard of Care Vascular Access Strategies
Figure 3-99: PICC and Midline Related Complications: A Multicenter Observational Study
Figure 3-100: Complications Associated With Central Venous Access
Figure 3-101: Evaluation of Electrocardiographic Guidance
Figure 3-102: Phase II Randomised Study Comparing the Tolerance of PICC Line
Figure 3-103: Randomized, Prospective, Single-center Study
Figure 3-104: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion
Figure 3-105: Ultrasound-guided Peripheral Vascular Access
Figure 3-106: Vascular Access in Cancer Patients
Figure 3-107: A Monocenter Prospective Study
Figure 3-108: Vascular Access in Hematological Patients
Figure 3-109: ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter (PICC) Tip
Figure 3-110: Sequential Pneumatic Compression
Figure 3-111: Reliability of Central Venous Pressure Measurements
Figure 3-112: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation
Figure 3-113: A Randomized Open-labeled Multicenter Study
Figure 3-114: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters
Figure 3-115: A Randomized Prospective Multicenter Evaluation
Figure 3-116: Randomized Double Blind Comparison
Figure 3-117: An Observational, Prospective, Single-center Study of Placement and Confirmation
Figure 3-118: PICC and Midline Related Complications
Figure 3-119: Contribution of Ultrasound for Peripheral Intravenous Catheter Placement by Intensive Care Nurses
Figure 3-120: A Comparison of Accuvein to Standard Intravenous Access
Figure 3-121: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access
Figure 3-122: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
Figure 3-123: Ultrasound-guided Peripheral Vascular Access in Children
Figure 3-124: Preventing Delay of Care in Patient With Difficult IV Access
Figure 3-125: A Randomized Control Trial of Ultrasound Guided IV Access
Figure 3-126: Removal Peripheral Intravenous Catheters According to Clinical Signs
Figure 3-127: Clinical Investigation Acc. to MPG §23b
Figure 3-128: Evaluation of Accuvein® in Obese Patients
Figure 3-129: A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device
Figure 3-130: Technique for Successful Ultrasound-guided Peripheral Vascular Access
Figure 3-131: A Randomized Controlled Open Label Trial
Figure 3-132: A Prospective Feasibility Trial of AccuCath® 2.25BC Intravascular Catheter System
Figure 3-133: The Use of a Topical Anesthetic Skin Refrigerant
Figure 3-134: A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein® IV Catheter
Figure 3-135: Observational Study of the Sonic Window™ Handheld Ultrasound System
Figure 3-136: Near-Infrared Software Performance Study
Figure 3-137: A Randomized Controlled Trial To Compare The Initial Success Rate
Figure 3-138: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter
Figure 3-139: Ultrasound Guided Peripheral Intravenous Catheter Insertion
Figure 3-140: Nurse Peripheral Intravenous Catheter Insertion Success
Figure 3-141: ACCESS HD Pilot
Figure 3-142: Randomized Controlled Trial of Straight Versus Coiled Peritoneal Dialysis
Figure 3-143: Randomized Trial Comparing VectorFlow™ Tunneled Dialysis Catheter
Figure 3-144: Duration and Adverse Events of Non-cuffed Catheter
Figure 3-145: Vascular Access Choice and Outcomes in the Elderly and Very Elderly
Figure 3-146: Prevention of Tunneled Cuffed Catheter Malfunction
Figure 3-147: Analysis of CRBSI
Figure 3-148: A Prospective Multicenter Investigation
Figure 3-149: Comparison of an Intensive Versus a Standard Hemodialysis Central Venous Catheter
Figure 3-150: Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter for Dialysis
Figure 3-151: Comparison of Self-locating Catheter Versus a Straight Catheter for Outflow Problems .. 163
Figure 3-152: Multi-Center, Prospective, Randomized, Open-Label, Sponsor-Blinded, Active-Control (Heparin) Clinical Investigation
Figure 3-153: Comparative Effectiveness of 30% Trisodium Citrate and Heparin Lock Solutions
Figure 3-154: The Use of Point of Care Ultra Sound for Correct Placement
Figure 3-155: Contribution of Ultrasound for Peripheral Intravenous Catheter
Figure 3-156: Evaluation of Electrocardiographic Guidance
Figure 3-157: Impact of Ultrasound Guided Central Venous Catheterization
Figure 3-158: A Comparison of Accuvein to Standard Intravenous Access
Figure 3-159: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access
Figure 3-160: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
Figure 3-161: Incidence of Complication Depending on the Cannulation Site
Figure 3-162: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion
Figure 3-163: Ultrasound-guided Peripheral Vascular Access in Children
Figure 3-164: Preventing Delay of Care in Patient With Difficult IV Access
Figure 3-165: Ultrasound-guided Peripheral Vascular Access
Figure 3-166: A Randomized Control Trial of Ultrasound Guided IV Access
Figure 3-167: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation
Figure 3-168: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography
Figure 3-169: ECG Versus Ultrasound-guided Positioning
Figure 3-170: SUBclavian Central Venous Catheters Guidance and Examination
Figure 3-171: Evaluation of Accuvein® in Obese Patients
Figure 3-172: Time and Motion Related to PICC Insertion Process
Figure 3-173: Technique for Successful Ultrasound-guided Peripheral Vascular Access
Figure 3-174: A Randomized Open-labeled Multicenter Study
Figure 3-175: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters
Figure 3-176: Ultrasound Guided Diagnosis of Central Venous Catheters in Children
Figure 3-177: Real-time Ultrasound-guided Catheterization of the Axillary Vein
Figure 3-178: Observational Study of the Sonic Window™ Handheld Ultrasound System
Figure 3-179: Ultrasound-guided Subclavian Vein Puncture
Figure 3-180: Near-Infrared Software Performance Study
Figure 3-181: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement
Figure 3-182: Interest of Ultrasound Coupled to a Guidance System (GPS)
Figure 3-183: A Randomized Controlled Trial
Figure 3-184: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter
Figure 3-185: Ultrasound Guided Peripheral Intravenous Catheter Insertion
Figure 3-186: An Observational, Prospective, Single-center Study
Figure 3-187: Nurse Peripheral Intravenous Catheter Insertion Success
Figure 3-188: Unit Based Comparison of Non-Versus Chlorhexidine-Impregnated Central Line Dressings
Figure 3-189: Use of Chlorhexidine-gel-Impregnated Dressing
Figure 3-190: Comparing SecurAcath® Versus StatLock®
Figure 3-191: Chlorhexidine Containing Iv-securement Dressings
Figure 3-192: A Randomized, Parallel Design Study
Figure 3-193: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
Figure 3-194: Transition From Parenteral Prostanoids to Inhaled Treprostinil
Figure 3-195: Efficacy, Safety and Acceptability of the New Pen Needle
Figure 3-196: A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity
Figure 3-197: A Single Centre, Randomised, 3-period Cross-over Trial
Figure 3-198: A Phase IV, Non-Inferiority, Observer Blind, Randomized Clinical Study
Figure 3-199: Treating Diabetic Lipohypertrophy With Intensive Education
Figure 3-200: Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin
Figure 3-201: A Randomized, Multi-centre Cross-over Study
Figure 3-202: A Clinical Investigation to Evaluate the Safety and Performance
Figure 3-203: A Phase I, Randomized, Open-Label, Parallel-Group, Single-Dose, Multi-Center Study
Figure 3-204: Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro
Figure 3-205: Reproducibility of Insulin Action When Administered by Needle-free Jet Injection
Figure 3-206: Patient Experiences With Injection Needles
Figure 3-207: Inactivated Influenza Via Jet Injection
Figure 3-208: Intradermal Rabies Immunization Using NanoJect: A Comparative Study
Figure 3-209: Phase 1b, Partial-Blind, Parallel Group, Randomized Study
Figure 3-210: A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report